Search results for "Highlights"


 
Results 101 - 110 of about 257 for "Highlights".

Incretin-based drugs not associated with greater heart failure hospitalization risk than other drug combos in retrospective study

Researchers compared patients taking dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues to those taking 2 or more oral antidiabetic drugs.
April 2016

New risk score for CVD may be easier to use than existing scores in patients with diabetes

Researchers used data from the ADVANCE-ON study to develop the AD-ON risk score, a 10-year risk score for the combined endpoint of major cardiovascular disease (CVD) or chronic kidney disease.
February 2016

FDA warns about ketoacidosis and urinary tract infections with SGLT2 inhibitors

The warnings are based on a review finding 73 cases of ketoacidosis in patients with type 1 or type 2 diabetes and 19 cases of life-threatening urosepsis and pyelonephritis.
December 2015

Glucose-lowering agents other than metformin associated with higher mortality in study

Compared to matched controls, patients on metformin monotherapy did not show significant excess mortality during follow-up, but patients on sulfonylurea or insulin monotherapy had higher mortality rates.
January 2016

Combined canagliflozin, metformin may offer better glycemic control than monotherapy, study finds

The industry-funded, double-blind, randomized, controlled trial assigned adult patients with type 2 diabetes who were not taking antihyperglycemic agents before the study to 26 weeks of treatment in 1 of 5 arms.
February 2016

Diabetes, prior CHD may not be equivalent CHD risk factors, study indicates

The population-based prospective cohort analysis of adults who were members of a single U.S. health care delivery system compared CHD risk among those with and without a history of diabetes or CHD.
January 2016

Collaboration between generalists, subspecialists can improve glycemic control

A “virtual clinic” model involving consultations between diabetes subspecialists and primary care physicians was associated with glycemic improvements in treated patients and controls from the same practices, a British study found.
December 2015

Patients with prediabetes diagnosis more likely to change health behaviors

The authors stated that the impact of prediabetes awareness on the odds of adopting risk-reducing lifestyle factors highlights the special influence of physician input on patient behavior.“ Increasing patients' awareness
July 2015

Review compares once-weekly GLP-1 receptor agonists to other diabetes meds

Once-weekly glucagon-like peptide 1 (GLP-1) receptor agonists lower HbA1c without increasing body weight, a review found.
October 2015

Mortality in diabetes may vary greatly by age, glycemic control, renal complications

Patients who were under age 55 faced a more substantial increase in mortality risk from having diabetes than older patients.
November 2015

Result Page: Prev   6   7   8   9   10   11   12   13   14   15   Next